tiprankstipranks
Trending News
More News >

Rani Therapeutics Faces Nasdaq Non-Compliance Notice

Story Highlights
  • Rani Therapeutics was notified by Nasdaq of non-compliance with the minimum bid price.
  • The company has until December 17, 2025, to rectify the issue or face potential delisting.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Rani Therapeutics Faces Nasdaq Non-Compliance Notice

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Rani Therapeutics Holdings ( (RANI) ).

On June 20, 2025, Rani Therapeutics Holdings, Inc. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement for its Class A common stock, which has been below $1.00 for 30 consecutive business days. The company has until December 17, 2025, to rectify this by achieving a minimum bid price of $1.00 per share for at least 10 consecutive business days. If compliance is not regained, the company may transfer to The Nasdaq Capital Market for an additional compliance period. Failure to meet these requirements could result in delisting.

The most recent analyst rating on (RANI) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Rani Therapeutics Holdings stock, see the RANI Stock Forecast page.

Spark’s Take on RANI Stock

According to Spark, TipRanks’ AI Analyst, RANI is a Underperform.

Rani Therapeutics Holdings’ overall stock score reflects significant financial struggles with no revenue and consistent net losses. The technical analysis shows a bearish trend, and the valuation is challenging with a negative P/E ratio. Strategic advancements in technology and potential partnerships are positive but are overshadowed by financial constraints and high leverage.

To see Spark’s full report on RANI stock, click here.

More about Rani Therapeutics Holdings

Average Trading Volume: 443,107

Technical Sentiment Signal: Sell

Current Market Cap: $29.12M

Find detailed analytics on RANI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1